Society guideline links: Uterine cancer

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●Society for Immunotherapy of Cancer (SITC): Clinical practice guideline on immunotherapy for the treatment of gynecologic cancer, update (2023, updated 2024)

●Gynecologic Groupe European de Curietherapie (GEC)-European Society for Radiation Therapy and Oncology (ESTRO), American Brachytherapy Society (ABS), and Canadian Brachytherapy Group (CBG): Consensus brachytherapy target definition guidelines for recurrent endometrial and cervical tumors in the vagina (2023)

●International Federation of Gynecology and Obstetrics (FIGO): Staging of endometrial cancer (2023)

●FIGO: Cancer report on cancer of the corpus uteri, update (2021)

●FIGO: Cancer report on uterine sarcomas (2018)

Canada

●Ontario Health (Cancer Care Ontario) (OH-CCO): Endometrial cancer molecular testing recommendations report (2024)

●Society of Obstetricians and Gynaecologists of Canada (SOGC): Clinical practice guideline on asymptomatic endometrial thickening in postmenopausal women (2024)

●CCO: Systemic therapy for advanced or recurrent endometrial cancer and advanced or recurrent uterine papillary serous carcinoma (2019)

●Society of Gynecologic Oncology of Canada (GOC)-SOGC: Joint clinical practice guideline on classification and management of endometrial hyperplasia (2019)

●CCO: Cancer screening for persons at risk for or affected with Lynch syndrome evidence summary (2018)

●SOGC: Clinical practice guideline on epidemiology and investigations for suspected endometrial cancer (reaffirmed 2018)

●CCO: Follow-up after primary therapy for endometrial cancer (2017)

●British Columbia Guidelines and Protocols and Advisory Committee (GPAC): Genital tract cancers in females – Endometrial cancer (2014)

United States

●National Cancer Institute (NCI): Uterine cancer – Health professional version

●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on tamoxifen and uterine cancer (2014, reaffirmed 2024)

●ACOG: Clinical consensus for management of endometrial intraepithelial neoplasia or atypical endometrial hyperplasia (2023)

●American Society for Radiation Oncology (ASTRO): Clinical practice guideline on radiation therapy for endometrial cancer (2023)

●Society of Gynecologic Oncology (SGO): A clinical practice statement on molecular testing for endometrial cancer (2023)

●American College of Radiology (ACR): ACR Appropriateness Criteria on pretreatment evaluation and follow-up of endometrial cancer (2020)

●SGO: A clinical practice statement on hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer (2020)

●American Society of Colon and Rectal Surgeons (ASCRS): Clinical practice guidelines for the surgical treatment of patients with Lynch syndrome (2017)

●SGO: Recommendations for post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies, update (2017)

●American Brachytherapy Society (ABS): Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer (2015)

●ACOG: Practice bulletin on endometrial cancer (2015)

●American Society of Clinical Oncology (ASCO): Clinical practice guideline endorsement of the ASTRO evidence-based guideline on postoperative radiation therapy for endometrial cancer (2015)

●SGO: Clinical practice statement on the role of sentinel lymph node mapping in endometrial cancer (2015)

●ACOG: Practice bulletin on Lynch syndrome (2014)

●SGO: Clinical practice statement on screening for Lynch syndrome in endometrial cancer (2014)

●US Multi-Society Task Force (USMSTF) on Colorectal Cancer: A consensus statement – Guidelines on genetic evaluation and management of Lynch syndrome (2014)

Europe

●European Society of Gynaecological Oncology (ESGO), European Reference Network on Rare Adult Solid Cancers (EURACAN), and Gynecologic Cancer InterGroup (GCIG): Guidelines for the management of patients with uterine sarcomas (2024)

●ESGO/European Society of Human Reproduction and Embryology (ESHRE)/European Society for Gynaecological Endoscopy (ESGE): Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma (2023)

●European Society for Medical Oncology (ESMO): Endometrial cancer – Clinical practice guideline for diagnosis, treatment, and follow-up (2022)

●ESGO/European SocieTy for Radiotherapy and Oncology (ESTRO)/European Society of Pathology (ESP): Guidelines for the management of patients with endometrial carcinoma (2021)

●European Hereditary Tumour Group (EHTG) and European Society of Coloproctology (ESCP): European guidelines on Lynch syndrome – An updated third edition of the Mallorca guidelines based on gene and gender (2021)

●ESGO: Quality indicators for the surgical treatment of endometrial carcinoma (2021)

●European Society of Urogenital Radiology (ESUR): Updated guidelines on endometrial cancer MRI staging (2019)

●ESMO-ESGO-ESTRO: Consensus conference on endometrial cancer – Diagnosis, treatment, and follow-up (2016)

United Kingdom

●British Association of Gynaecological Pathologists (BAGP)/British Gynaecological Cancer Society (BGCS): Guidance on POLE NGS testing in endometrial carcinoma (2022)

●BGCS: Uterine cancer guidelines – Recommendations for practice (2022)

●National Institute for Health and Care Excellence (NICE): Diagnostics guidance on testing strategies for Lynch syndrome in people with endometrial cancer (2020)

●Royal College of Obstetricians and Gynaecologists (RCOG)/British Society for Gynaecological Endoscopy (BSGE): Green-top guideline for management of endometrial hyperplasia (2016)

India

●Chinese Society of Clinical Oncology (CSCO), Indian Society of Medical and Paediatric Oncology (ISMPO), Indonesian Society of Hematology and Medical Oncology (ISHMO), Japanese Society of Medical Oncology (JSMO), Korean Society for Medical Oncology (KSMO), Malaysian Oncological Society (MOS), Philippine Society of Medical Oncology (PSMO), Singapore Society of Oncology (SSO), Taiwan Oncology Society (TOS), Thai Society of Clinical Oncology (TSCO): Pan-Asian adapted European Society for Medical Oncology (ESMO) clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with endometrial cancer (2023)

Australia–New Zealand

●Cancer Australia: Optimal care pathway for women with endometrial cancer, second edition (2021)

●Cancer Australia: Shared follow-up care for women with low-risk endometrial cancer – A guide for general practitioners (2020)

Japan

●[In English] Chinese Society of Clinical Oncology (CSCO), Indian Society of Medical and Paediatric Oncology (ISMPO), Indonesian Society of Hematology and Medical Oncology (ISHMO), Japanese Society of Medical Oncology (JSMO), Korean Society for Medical Oncology (KSMO), Malaysian Oncological Society (MOS), Philippine Society of Medical Oncology (PSMO), Singapore Society of Oncology (SSO), Taiwan Oncology Society (TOS), Thai Society of Clinical Oncology (TSCO): Pan-Asian adapted European Society for Medical Oncology (ESMO) clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with endometrial cancer (2023)

●[In Japanese] Japanese Society of Gynecologic Oncology (JSGO): Endometrial cancer treatment guidelines (2023)